Carregant...

Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer’s Disease

The NIA-AA criteria for “preclinical” Alzheimer’s disease (AD) propose a staging method in which AD biomarkers follow an invariable temporal sequence in accordance with the amyloid cascade hypothesis. However, recent findings do not align with the proposed temporal sequence and “subtle cognitive dec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Alzheimers Dis
Autors principals: Edmonds, Emily C., Delano-Wood, Lisa, Galasko, Douglas R., Salmon, David P., Bondi, Mark W.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634634/
https://ncbi.nlm.nih.gov/pubmed/26402771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-150128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!